November 20, 2024

Genetic GERD Linked to Cardiovascular, Hypertension Risks

Genetically predicted gastroesophageal reflux disease may significantly increase the risk of myocardial infarction and hypertension.

Conexiant

November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

November 19, 2024

Does Blood Pressure Variability Affect Visual Field Loss in Glaucoma?

Higher mean BP and higher BP variability were associated with faster VF deterioration.

Conexiant

November 19, 2024

Predicting ICH Causes: MRI Advantage

Conexiant

November 19, 2024

Gantenerumab Linked to ARIA Risk in Early Alzheimer's Disease

86% of ARIA-E cases occurred within the first 64 weeks of gantenerumab treatment, with APOE ε4 homozygotes showing nearly 5-fold increased risk.

Conexiant

November 19, 2024

Analysis Maps Broad Semaglutide Eligibility

An estimated 136.8 million U.S. adults are eligible for semaglutide, a number exceeding current eligibility for statins, according to an analysis.

Conexiant

November 19, 2024

Kimchi Consumption Reduces Body Fat, Clinical Trial Shows

Trial reveals kimchi's dual action: consuming 3000 mg daily not only reduced body fat mass but also increased beneficial gut bacteria A. muciniphila while decreasing obesity-associated microbes.

Conexiant

November 19, 2024

Novel Stroke Drug Shows 12-Hour Window

Despite a median treatment time of 9.5 hours after stroke onset - more than twice the current therapeutic window - JX10 showed significantly better functional outcomes than placebo with no symptomatic intracranial hemorrhage events.

Conexiant

November 19, 2024

Lilly Pill Lowers Lp(a) Up to 86%: Study

Reuters